HIGHLIGHTS
- who: Cardiomyopathy via NLRP and collaborators from the School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China have published the paper: The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway, in the Journal: Evidence-Based Complementary and Alternative Medicine of 31/07/2022
- how: Te docking results suggested that SMY may act on and its downstream signal Te in vivo results showed that SMY could reduce blood glucose and lipid levels improve heart function improve histopathological changes and myocardial enzymes and alleviate cardiomyocyte apoptosis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.